MHRA approves stronger dosage of weight-loss medication
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a new maximum weekly dose of semaglutide of up to 7.2mg. The regulatory agency shares that this is designed to
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a new maximum weekly dose of semaglutide of up to 7.2mg. The regulatory agency shares that this is designed to
A review published in the British Medical Journal indicates that individuals using weight-loss medication may regain lost weight up to four times faster than those who lose weight through conventional